S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CPIX Cumberland Pharmaceutical Inc

6.76

0.71 (11.74%)

06 Mar 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Cumberland Pharmaceutical (NASDAQ:CPIX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Cumberland Pharmaceutical Charts.

Cumberland Pharmaceutical (NASDAQ:CPIX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Cumberland Pharmaceutical Charts.

Cumberland Pharmaceutical Inc News

Form 8-K - Current report
Wednesday 5 March 2025 (1 day ago) • Edgar (US Regulatory)

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth
Wednesday 5 March 2025 (1 day ago) • PR Newswire (US)

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS
Wednesday 26 February 2025 (1 week ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA
Tuesday 18 February 2025 (2 weeks ago) • PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 12 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Pharma Stock Soars On Phase 2 Announcement
Wednesday 5 February 2025 (4 weeks ago) • AllPennyStocks.com

Form 8-K - Current report
Wednesday 5 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
Tuesday 4 February 2025 (4 weeks ago) • PR Newswire (US)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Friday 31 January 2025 (1 month ago) • Edgar (US Regulatory)

More Cumberland Pharmaceutical Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions